Jonathan Ross Goodman founded Paladin Labs, Inc. and Knight Therapeutics, Inc. Presently, Mr. Goodman holds the position of Executive Chairman for Knight Therapeutics, Inc. and Advisor at Maverix Private Equity. Mr. Goodman is also on the board of Medison Biotech 1995 Ltd., POINT Biopharma Corp., POINT Biopharma Global, Inc. and POINT Biopharma, Inc. (United States) and Member of New York State Bar Association and Member of Massachusetts Bar Association.

In his past career Jonathan Ross Goodman occupied the position of Principal at Procter & Gamble Co., Consultant at Bain & Co., Inc., Vice President-Business Development of Pharmascience, Inc., Chairman, President & Chief Executive Officer for Paladin Labs, Inc., Chairman of Isotechnika, Inc. and Chairman of Isotechnika Pharma, Inc.

He received an undergraduate degree from London School of Economics & Political Science and an undergraduate degree, a graduate degree and an MBA from McGill University.